Drug Detail:Tecfidera (Dimethyl fumarate [ dye-meth-il-fue-mar-ate ])
Generic Name: dimethyl fumarate 120mg; dimethyl fumarate 240mg
Dosage Form: capsules
Drug Class: Selective immunosuppressants
Drug Detail:Tecfidera (Dimethyl fumarate [ dye-meth-il-fue-mar-ate ])
Generic Name: dimethyl fumarate 120mg; dimethyl fumarate 240mg
Dosage Form: capsules
Drug Class: Selective immunosuppressants
The starting dose for TECFIDERA is 120 mg twice a day orally. After 7 days, the dose should be increased to the maintenance dose of 240 mg twice a day orally. Temporary dose reductions to 120 mg twice a day may be considered for individuals who do not tolerate the maintenance dose. Within 4 weeks, the recommended dose of 240 mg twice a day should be resumed. Discontinuation of TECFIDERA should be considered for patients unable to tolerate return to the maintenance dose. The incidence of flushing may be reduced by administration of TECFIDERA with food. Alternatively, administration of non-enteric coated aspirin (up to a dose of 325 mg) 30 minutes prior to TECFIDERA dosing may reduce the incidence or severity of flushing [see Clinical Pharmacology (12.3)].
TECFIDERA should be swallowed whole and intact. TECFIDERA should not be crushed or chewed, and the capsule contents should not be sprinkled on food. TECFIDERA can be taken with or without food.
Obtain a complete blood cell count (CBC) including lymphocyte count before initiation of therapy [see Warnings and Precautions (5.4)].
Obtain serum aminotransferase, alkaline phosphatase, and total bilirubin levels prior to treatment with TECFIDERA [see Warnings and Precautions (5.5)].